Published in An Bras Dermatol on February 22, 2017
Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation (2002) 76.93
Risk of myocardial infarction in patients with psoriasis. JAMA (2006) 9.42
Prevalence of cardiovascular risk factors in patients with psoriasis. J Am Acad Dermatol (2006) 4.12
Cigarette smoking, body mass index, and stressful life events as risk factors for psoriasis: results from an Italian case-control study. J Invest Dermatol (2005) 3.18
The risk of stroke in patients with psoriasis. J Invest Dermatol (2009) 2.97
Increased prevalence of the metabolic syndrome in patients with moderate to severe psoriasis. Arch Dermatol Res (2006) 2.67
Prevalence of metabolic syndrome in patients with psoriasis: a hospital-based case-control study. Br J Dermatol (2007) 2.40
Prevalence of metabolic syndrome in patients with psoriasis: a population-based study in the United Kingdom. J Invest Dermatol (2011) 2.36
The risk of mortality in patients with psoriasis: results from a population-based study. Arch Dermatol (2007) 2.32
Prevalence of the metabolic syndrome in psoriasis: results from the National Health and Nutrition Examination Survey, 2003-2006. Arch Dermatol (2010) 2.29
Psoriasis and metabolic disease: epidemiology and pathophysiology. Curr Opin Rheumatol (2008) 2.25
Impact of obesity and smoking on psoriasis presentation and management. Arch Dermatol (2005) 2.15
Quality of life in patients with psoriasis: a systematic literature review. J Investig Dermatol Symp Proc (2004) 1.95
Psoriasis and the risk of diabetes and hypertension: a prospective study of US female nurses. Arch Dermatol (2009) 1.91
Psoriasis is associated with lipid abnormalities at the onset of skin disease. J Am Acad Dermatol (2006) 1.41
Psoriasis and metabolic syndrome: a systematic review and meta-analysis of observational studies. J Am Acad Dermatol (2013) 1.33
Prevalence of metabolic syndrome in patients with psoriasis. Indian J Dermatol Venereol Leprol (2010) 1.30
Psoriasis and the risk of diabetes mellitus: a systematic review and meta-analysis. JAMA Dermatol (2013) 1.29
Prevalence of metabolic syndrome in South Indian patients with psoriasis vulgaris and the relation between disease severity and metabolic syndrome: a hospital-based case-control study. Indian J Dermatol (2012) 1.28
Psoriasis independently associated with hyperleptinemia contributing to metabolic syndrome. Arch Dermatol (2008) 1.23
Comorbidities in psoriasis patients. Semin Cutan Med Surg (2010) 1.21
Psoriasis and diabetes: a population-based cross-sectional study. J Eur Acad Dermatol Venereol (2008) 1.18
Psoriasis and the risk of incident diabetes mellitus: a population-based study. Br J Dermatol (2008) 1.14
Cardiovascular risk factors in patients with plaque psoriasis: a systematic review of epidemiological studies. J Eur Acad Dermatol Venereol (2010) 1.13
Analysis of cardiovascular risk factors and metabolic syndrome in korean patients with psoriasis. Ann Dermatol (2012) 1.05
Prevalence of metabolic syndrome in patients with psoriasis. ScientificWorldJournal (2012) 1.01
C-reactive protein and alpha2-macroglobulin plasma activity in medium-severe and severe psoriasis. J Eur Acad Dermatol Venereol (2004) 1.01
Metabolic syndrome in Tunisian psoriatic patients: prevalence and determinants. J Eur Acad Dermatol Venereol (2010) 0.99
Psoriasis and metabolic syndrome. J Dermatol (2011) 0.98
Association between Psoriasis and Cardiovascular Risk Factors in Korean Patients. Ann Dermatol (2010) 0.97
The association between psoriasis and hypertension: a systematic review and meta-analysis of observational studies. J Hypertens (2013) 0.96
Scoring and monitoring the severity of psoriasis. What is the preferred method? What is the ideal method? Is PASI passé? facts and controversies. Clin Dermatol (2010) 0.95
Prevalence of metabolic syndrome in Japanese psoriasis patients. J Dermatol Sci (2009) 0.94
Psoriasis is a systemic disease with multiple cardiovascular and metabolic comorbidities. Dermatol Clin (2015) 0.94
Psoriasis and smoking: a systematic review and meta-analysis. Br J Dermatol (2014) 0.92
Metabolic comorbidities and psoriasis. Acta Dermatovenerol Croat (2010) 0.91
Psoriasis and the metabolic syndrome. Dermatol Ther (2010) 0.87
Comorbidities and cardiovascular risk factors in patients with psoriasis. An Bras Dermatol (2014) 0.85
Psoriasis and physical activity: a review. J Eur Acad Dermatol Venereol (2012) 0.81
Health-related quality of life in patients with psoriasis. J Cutan Med Surg (2011) 0.81
Prevalence of obesity/adiposity in Japanese psoriasis patients: adiposity is correlated with the severity of psoriasis. J Dermatol Sci (2009) 0.79
The association of metabolic syndrome and psoriasis: a population- and hospital-based cross-sectional study. J Eur Acad Dermatol Venereol (2014) 0.77
Assessment of quality of life in patients with psoriasis: a study from Serbia. Int J Dermatol (2014) 0.76